[
    {
        "id": 9440,
        "drug_name": "FYLNETRA (pegfilgrastim-pbbk)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Neulasta biosimilar ",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-05-27",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/AMRX\/news\/82000",
        "note": "Approved May 27, 2022. ",
        "company_entity_id": 543,
        "company_ticker": "AMRX",
        "company_name": "Amneal Pharmaceuticals Inc.",
        "company_price": "5.3100",
        "company_change": -0.06999999999999995,
        "company_percent_change": -1.3,
        "company_optionable": 1,
        "company_number_of_shares": 306544199,
        "price_change_sparkline": [
            [
                5.35,
                1706677200
            ],
            [
                5.51,
                1706763600
            ],
            [
                5.52,
                1706850000
            ],
            [
                5.52,
                1707109200
            ],
            [
                5.6,
                1707195600
            ],
            [
                5.36,
                1707282000
            ],
            [
                5.46,
                1707368400
            ],
            [
                5.57,
                1707454800
            ],
            [
                5.85,
                1707714000
            ],
            [
                5.6,
                1707800400
            ],
            [
                5.82,
                1707886800
            ],
            [
                5.89,
                1707973200
            ],
            [
                5.9,
                1708059600
            ],
            [
                5.78,
                1708405200
            ],
            [
                5.73,
                1708491600
            ],
            [
                5.69,
                1708578000
            ],
            [
                5.8,
                1708664400
            ],
            [
                5.82,
                1708923600
            ],
            [
                5.71,
                1709010000
            ],
            [
                5.52,
                1709096400
            ],
            [
                5.52,
                1709182800
            ],
            [
                5.47,
                1709269200
            ],
            [
                5.4,
                1709528400
            ],
            [
                5.34,
                1709614800
            ],
            [
                5.31,
                1709701200
            ],
            [
                5.31,
                1709787600
            ],
            [
                5.39,
                1709874000
            ],
            [
                5.38,
                1710129600
            ],
            [
                5.31,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5429,
        "drug_name": "OPDIVO (nivolumab) + YERVOY (ipilimumab) - (CM-648)",
        "clinical_trial_id": "NCT03143153",
        "has_trial_insight_page": 0,
        "indication": "Esophageal squamous cell carcinoma (ESCC)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-05-27",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BMY\/news\/82062",
        "note": "Approved May 27, 2022. ",
        "company_entity_id": 376,
        "company_ticker": "BMY",
        "company_name": "Bristol-Myers Squibb Company",
        "company_price": "54.4000",
        "company_change": 0.04,
        "company_percent_change": 0.07,
        "company_optionable": 1,
        "company_number_of_shares": 2022193411,
        "price_change_sparkline": [
            [
                48.87,
                1706677200
            ],
            [
                48.67,
                1706763600
            ],
            [
                48.71,
                1706850000
            ],
            [
                47.98,
                1707109200
            ],
            [
                49.26,
                1707195600
            ],
            [
                48.64,
                1707282000
            ],
            [
                48.71,
                1707368400
            ],
            [
                49.81,
                1707454800
            ],
            [
                49.75,
                1707714000
            ],
            [
                48.71,
                1707800400
            ],
            [
                48.89,
                1707886800
            ],
            [
                49.44,
                1707973200
            ],
            [
                49.86,
                1708059600
            ],
            [
                49.86,
                1708405200
            ],
            [
                50.91,
                1708491600
            ],
            [
                51.33,
                1708578000
            ],
            [
                51.66,
                1708664400
            ],
            [
                50.52,
                1708923600
            ],
            [
                50.51,
                1709010000
            ],
            [
                50.92,
                1709096400
            ],
            [
                50.75,
                1709182800
            ],
            [
                50.89,
                1709269200
            ],
            [
                50.92,
                1709528400
            ],
            [
                51.82,
                1709614800
            ],
            [
                53.38,
                1709701200
            ],
            [
                53.28,
                1709787600
            ],
            [
                53.79,
                1709874000
            ],
            [
                54.36,
                1710129600
            ],
            [
                54.4,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 8899,
        "drug_name": "Evrysdi (risdiplam)",
        "clinical_trial_id": "NCT03779334",
        "has_trial_insight_page": 0,
        "indication": "Spinal Muscular Atrophy (SMA) in babies",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-05-31",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/RHHBY\/news\/82132",
        "note": "Approved May 31, 2022. ",
        "company_entity_id": 536,
        "company_ticker": "RHHBY",
        "company_name": "Roche Holding AG ADR",
        "company_price": "35.1500",
        "company_change": 0.54,
        "company_percent_change": 1.56,
        "company_optionable": 0,
        "company_number_of_shares": 6389213336,
        "price_change_sparkline": [
            [
                35.14,
                1706677200
            ],
            [
                34.32,
                1706763600
            ],
            [
                33.95,
                1706850000
            ],
            [
                33.16,
                1707109200
            ],
            [
                33.27,
                1707195600
            ],
            [
                32.55,
                1707282000
            ],
            [
                32.1,
                1707368400
            ],
            [
                32.31,
                1707454800
            ],
            [
                32.6,
                1707714000
            ],
            [
                32.13,
                1707800400
            ],
            [
                32.02,
                1707886800
            ],
            [
                32.1,
                1707973200
            ],
            [
                32.28,
                1708059600
            ],
            [
                32.74,
                1708405200
            ],
            [
                32.91,
                1708491600
            ],
            [
                32.49,
                1708578000
            ],
            [
                32.96,
                1708664400
            ],
            [
                32.52,
                1708923600
            ],
            [
                33.03,
                1709010000
            ],
            [
                32.93,
                1709096400
            ],
            [
                32.73,
                1709182800
            ],
            [
                33.08,
                1709269200
            ],
            [
                32.88,
                1709528400
            ],
            [
                33.15,
                1709614800
            ],
            [
                33.47,
                1709701200
            ],
            [
                33.77,
                1709787600
            ],
            [
                33.9,
                1709874000
            ],
            [
                34.61,
                1710129600
            ],
            [
                35.15,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 8899,
        "drug_name": "Evrysdi (risdiplam)",
        "clinical_trial_id": "NCT03779334",
        "has_trial_insight_page": 0,
        "indication": "Spinal Muscular Atrophy (SMA) in babies",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-05-31",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/RHHBY\/news\/82132",
        "note": "Approved May 31, 2022. ",
        "company_entity_id": 251,
        "company_ticker": "PTCT",
        "company_name": "PTC Therapeutics Inc.",
        "company_price": "31.6900",
        "company_change": 0.99,
        "company_percent_change": 3.22,
        "company_optionable": 1,
        "company_number_of_shares": 76608030,
        "price_change_sparkline": [
            [
                26.09,
                1706677200
            ],
            [
                26.03,
                1706763600
            ],
            [
                25.18,
                1706850000
            ],
            [
                25.07,
                1707109200
            ],
            [
                26.79,
                1707195600
            ],
            [
                25.24,
                1707282000
            ],
            [
                25.25,
                1707368400
            ],
            [
                25.51,
                1707454800
            ],
            [
                25.92,
                1707714000
            ],
            [
                24.15,
                1707800400
            ],
            [
                25.04,
                1707886800
            ],
            [
                25.69,
                1707973200
            ],
            [
                25.91,
                1708059600
            ],
            [
                25.98,
                1708405200
            ],
            [
                25.94,
                1708491600
            ],
            [
                26.04,
                1708578000
            ],
            [
                27.07,
                1708664400
            ],
            [
                27.95,
                1708923600
            ],
            [
                28.31,
                1709010000
            ],
            [
                28.2,
                1709096400
            ],
            [
                28.19,
                1709182800
            ],
            [
                31.95,
                1709269200
            ],
            [
                30.98,
                1709528400
            ],
            [
                31.3,
                1709614800
            ],
            [
                30.88,
                1709701200
            ],
            [
                30.76,
                1709787600
            ],
            [
                31.16,
                1709874000
            ],
            [
                30.7,
                1710129600
            ],
            [
                31.69,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9466,
        "drug_name": "RIABNI (rituximab-arrx) with methotrexate - (Rituxan biosimilar)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Rheumatoid arthritis (RA)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-06",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/AMGN\/news\/83082",
        "note": "Approved June 6, 2022. ",
        "company_entity_id": 372,
        "company_ticker": "AMGN",
        "company_name": "Amgen Inc.",
        "company_price": "276.5400",
        "company_change": 1.18,
        "company_percent_change": 0.43,
        "company_optionable": 1,
        "company_number_of_shares": 535918901,
        "price_change_sparkline": [
            [
                311.832823699025,
                1706677200
            ],
            [
                322.053272003295,
                1706763600
            ],
            [
                320.693853151174,
                1706850000
            ],
            [
                319.483275779212,
                1707109200
            ],
            [
                313.62884422628,
                1707195600
            ],
            [
                293.584858231498,
                1707282000
            ],
            [
                292.572736166415,
                1707368400
            ],
            [
                288.871544693121,
                1707454800
            ],
            [
                292.155980021969,
                1707714000
            ],
            [
                288.236487711108,
                1707800400
            ],
            [
                287.829654332006,
                1707886800
            ],
            [
                289.07,
                1707973200
            ],
            [
                283.7,
                1708059600
            ],
            [
                283.51,
                1708405200
            ],
            [
                283.46,
                1708491600
            ],
            [
                285.18,
                1708578000
            ],
            [
                289.18,
                1708664400
            ],
            [
                286.37,
                1708923600
            ],
            [
                278.49,
                1709010000
            ],
            [
                277.46,
                1709096400
            ],
            [
                273.83,
                1709182800
            ],
            [
                280.33,
                1709269200
            ],
            [
                279.39,
                1709528400
            ],
            [
                276.65,
                1709614800
            ],
            [
                276.59,
                1709701200
            ],
            [
                272.86,
                1709787600
            ],
            [
                273.75,
                1709874000
            ],
            [
                275.36,
                1710129600
            ],
            [
                276.54,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9467,
        "drug_name": "PRIORIX",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Measles, mumps and rubella (MMR)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-06",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/GSK\/news\/83092",
        "note": "Approved June 6, 2022.",
        "company_entity_id": 379,
        "company_ticker": "GSK",
        "company_name": "GSK plc American Depositary Shares (Each representing two)",
        "company_price": "43.2700",
        "company_change": 0.35,
        "company_percent_change": 0.82,
        "company_optionable": 1,
        "company_number_of_shares": 2058516719,
        "price_change_sparkline": [
            [
                39.0637603938206,
                1706677200
            ],
            [
                40.2424083367376,
                1706763600
            ],
            [
                40.3315497777986,
                1706850000
            ],
            [
                41.1734411655964,
                1707109200
            ],
            [
                41.3517240477183,
                1707195600
            ],
            [
                41.6191483709012,
                1707282000
            ],
            [
                41.4210562796546,
                1707368400
            ],
            [
                41.5101977207156,
                1707454800
            ],
            [
                40.67821093748,
                1707714000
            ],
            [
                40.9951582834745,
                1707800400
            ],
            [
                41.40124707053,
                1707886800
            ],
            [
                41.371533256843,
                1707973200
            ],
            [
                41.5399115344025,
                1708059600
            ],
            [
                41.6191483709012,
                1708405200
            ],
            [
                41.5399115344025,
                1708491600
            ],
            [
                42.16,
                1708578000
            ],
            [
                42.22,
                1708664400
            ],
            [
                42.34,
                1708923600
            ],
            [
                42.38,
                1709010000
            ],
            [
                42.34,
                1709096400
            ],
            [
                41.9,
                1709182800
            ],
            [
                42.03,
                1709269200
            ],
            [
                42.44,
                1709528400
            ],
            [
                42.6,
                1709614800
            ],
            [
                42.62,
                1709701200
            ],
            [
                43.58,
                1709787600
            ],
            [
                43.14,
                1709874000
            ],
            [
                42.92,
                1710129600
            ],
            [
                43.27,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 8187,
        "drug_name": "DUPIXENT (dupilumab)",
        "clinical_trial_id": "NCT03346434",
        "has_trial_insight_page": 0,
        "indication": "Atopic dermatitis in 6 months - 5 year-olds",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-07",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SNY\/news\/83297",
        "note": "Approved June 7, 2022. ",
        "company_entity_id": 388,
        "company_ticker": "REGN",
        "company_name": "Regeneron Pharmaceuticals Inc.",
        "company_price": "970.5700",
        "company_change": 6.13,
        "company_percent_change": 0.64,
        "company_optionable": 1,
        "company_number_of_shares": 109761896,
        "price_change_sparkline": [
            [
                942.78,
                1706677200
            ],
            [
                957.78,
                1706763600
            ],
            [
                945.18,
                1706850000
            ],
            [
                936.33,
                1707109200
            ],
            [
                937.81,
                1707195600
            ],
            [
                938.49,
                1707282000
            ],
            [
                946.43,
                1707368400
            ],
            [
                953.42,
                1707454800
            ],
            [
                947.06,
                1707714000
            ],
            [
                940.48,
                1707800400
            ],
            [
                947.82,
                1707886800
            ],
            [
                954.73,
                1707973200
            ],
            [
                948.05,
                1708059600
            ],
            [
                946.87,
                1708405200
            ],
            [
                952.84,
                1708491600
            ],
            [
                964.89,
                1708578000
            ],
            [
                981.2,
                1708664400
            ],
            [
                989.28,
                1708923600
            ],
            [
                993.35,
                1709010000
            ],
            [
                987.61,
                1709096400
            ],
            [
                966.09,
                1709182800
            ],
            [
                982.82,
                1709269200
            ],
            [
                971.19,
                1709528400
            ],
            [
                965.21,
                1709614800
            ],
            [
                972.1,
                1709701200
            ],
            [
                973.31,
                1709787600
            ],
            [
                968.83,
                1709874000
            ],
            [
                964.44,
                1710129600
            ],
            [
                970.57,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7706,
        "drug_name": "OLUMIANT (baricitinib)",
        "clinical_trial_id": "NCT03570749",
        "has_trial_insight_page": 0,
        "indication": "Alopecia Areata",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-13",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LLY",
        "note": "Approval announced June 13, 2022.",
        "company_entity_id": 382,
        "company_ticker": "LLY",
        "company_name": "Eli Lilly and Company",
        "company_price": "754.9500",
        "company_change": 20.58,
        "company_percent_change": 2.8,
        "company_optionable": 1,
        "company_number_of_shares": 950164452,
        "price_change_sparkline": [
            [
                644.503643637706,
                1706677200
            ],
            [
                659.298247188938,
                1706763600
            ],
            [
                666.505874560051,
                1706850000
            ],
            [
                704.989812947364,
                1707109200
            ],
            [
                703.821817930162,
                1707195600
            ],
            [
                724.13694493877,
                1707282000
            ],
            [
                734.41929423551,
                1707368400
            ],
            [
                738.891617036422,
                1707454800
            ],
            [
                735.996586651903,
                1707714000
            ],
            [
                741.696801650387,
                1707800400
            ],
            [
                757.31,
                1707886800
            ],
            [
                757.78,
                1707973200
            ],
            [
                782.06,
                1708059600
            ],
            [
                755.66,
                1708405200
            ],
            [
                745.91,
                1708491600
            ],
            [
                769.64,
                1708578000
            ],
            [
                769.54,
                1708664400
            ],
            [
                771.92,
                1708923600
            ],
            [
                765,
                1709010000
            ],
            [
                757.64,
                1709096400
            ],
            [
                753.68,
                1709182800
            ],
            [
                782.12,
                1709269200
            ],
            [
                792.28,
                1709528400
            ],
            [
                777.59,
                1709614800
            ],
            [
                779.77,
                1709701200
            ],
            [
                780.16,
                1709787600
            ],
            [
                762.14,
                1709874000
            ],
            [
                734.37,
                1710129600
            ],
            [
                754.95,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7706,
        "drug_name": "OLUMIANT (baricitinib)",
        "clinical_trial_id": "NCT03570749",
        "has_trial_insight_page": 0,
        "indication": "Alopecia Areata",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-13",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LLY",
        "note": "Approval announced June 13, 2022.",
        "company_entity_id": 167,
        "company_ticker": "INCY",
        "company_name": "Incyte Corporation",
        "company_price": "59.3300",
        "company_change": -1.46,
        "company_percent_change": -2.4,
        "company_optionable": 1,
        "company_number_of_shares": 224526128,
        "price_change_sparkline": [
            [
                58.77,
                1706677200
            ],
            [
                59.16,
                1706763600
            ],
            [
                58.35,
                1706850000
            ],
            [
                58.06,
                1707109200
            ],
            [
                59.63,
                1707195600
            ],
            [
                57.34,
                1707282000
            ],
            [
                57.36,
                1707368400
            ],
            [
                57.66,
                1707454800
            ],
            [
                57.84,
                1707714000
            ],
            [
                59.34,
                1707800400
            ],
            [
                57.89,
                1707886800
            ],
            [
                58.97,
                1707973200
            ],
            [
                57.96,
                1708059600
            ],
            [
                58.82,
                1708405200
            ],
            [
                60.33,
                1708491600
            ],
            [
                60.91,
                1708578000
            ],
            [
                60.59,
                1708664400
            ],
            [
                60.53,
                1708923600
            ],
            [
                61,
                1709010000
            ],
            [
                59.98,
                1709096400
            ],
            [
                58.36,
                1709182800
            ],
            [
                59.05,
                1709269200
            ],
            [
                59.72,
                1709528400
            ],
            [
                58.9,
                1709614800
            ],
            [
                59.26,
                1709701200
            ],
            [
                59.03,
                1709787600
            ],
            [
                60.02,
                1709874000
            ],
            [
                60.79,
                1710129600
            ],
            [
                59.33,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3913,
        "drug_name": "AMVUTTRA (vutrisiran)",
        "clinical_trial_id": "NCT03759379",
        "has_trial_insight_page": 1,
        "indication": "Hereditary transthyretin-mediated (hATTR) amyloidosis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-14",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ALNY\/news\/83839",
        "note": "Approved June 14, 2022. ",
        "company_entity_id": 32,
        "company_ticker": "ALNY",
        "company_name": "Alnylam Pharmaceuticals Inc.",
        "company_price": "146.6500",
        "company_change": -2.45,
        "company_percent_change": -1.6400000000000001,
        "company_optionable": 1,
        "company_number_of_shares": 125945793,
        "price_change_sparkline": [
            [
                172.91,
                1706677200
            ],
            [
                174.92,
                1706763600
            ],
            [
                173.06,
                1706850000
            ],
            [
                170.7,
                1707109200
            ],
            [
                172.18,
                1707195600
            ],
            [
                168.6,
                1707282000
            ],
            [
                169.5,
                1707368400
            ],
            [
                170.03,
                1707454800
            ],
            [
                169.34,
                1707714000
            ],
            [
                162,
                1707800400
            ],
            [
                164.15,
                1707886800
            ],
            [
                147.43,
                1707973200
            ],
            [
                147,
                1708059600
            ],
            [
                149.69,
                1708405200
            ],
            [
                154.74,
                1708491600
            ],
            [
                162.81,
                1708578000
            ],
            [
                157.65,
                1708664400
            ],
            [
                158.66,
                1708923600
            ],
            [
                159,
                1709010000
            ],
            [
                155.23,
                1709096400
            ],
            [
                151.09,
                1709182800
            ],
            [
                152.61,
                1709269200
            ],
            [
                150.04,
                1709528400
            ],
            [
                149.68,
                1709614800
            ],
            [
                149.66,
                1709701200
            ],
            [
                149.86,
                1709787600
            ],
            [
                149.82,
                1709874000
            ],
            [
                149.1,
                1710129600
            ],
            [
                146.65,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5349,
        "drug_name": "OLUMIANT (baricitinib)",
        "clinical_trial_id": "NCT03899259",
        "has_trial_insight_page": 0,
        "indication": "Alopecia Areata",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-14",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LLY\/news\/83857",
        "note": "Approved June 14, 2022. ",
        "company_entity_id": 382,
        "company_ticker": "LLY",
        "company_name": "Eli Lilly and Company",
        "company_price": "754.9500",
        "company_change": 20.58,
        "company_percent_change": 2.8,
        "company_optionable": 1,
        "company_number_of_shares": 950164452,
        "price_change_sparkline": [
            [
                644.503643637706,
                1706677200
            ],
            [
                659.298247188938,
                1706763600
            ],
            [
                666.505874560051,
                1706850000
            ],
            [
                704.989812947364,
                1707109200
            ],
            [
                703.821817930162,
                1707195600
            ],
            [
                724.13694493877,
                1707282000
            ],
            [
                734.41929423551,
                1707368400
            ],
            [
                738.891617036422,
                1707454800
            ],
            [
                735.996586651903,
                1707714000
            ],
            [
                741.696801650387,
                1707800400
            ],
            [
                757.31,
                1707886800
            ],
            [
                757.78,
                1707973200
            ],
            [
                782.06,
                1708059600
            ],
            [
                755.66,
                1708405200
            ],
            [
                745.91,
                1708491600
            ],
            [
                769.64,
                1708578000
            ],
            [
                769.54,
                1708664400
            ],
            [
                771.92,
                1708923600
            ],
            [
                765,
                1709010000
            ],
            [
                757.64,
                1709096400
            ],
            [
                753.68,
                1709182800
            ],
            [
                782.12,
                1709269200
            ],
            [
                792.28,
                1709528400
            ],
            [
                777.59,
                1709614800
            ],
            [
                779.77,
                1709701200
            ],
            [
                780.16,
                1709787600
            ],
            [
                762.14,
                1709874000
            ],
            [
                734.37,
                1710129600
            ],
            [
                754.95,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5349,
        "drug_name": "OLUMIANT (baricitinib)",
        "clinical_trial_id": "NCT03899259",
        "has_trial_insight_page": 0,
        "indication": "Alopecia Areata",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-14",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LLY\/news\/83857",
        "note": "Approved June 14, 2022. ",
        "company_entity_id": 167,
        "company_ticker": "INCY",
        "company_name": "Incyte Corporation",
        "company_price": "59.3300",
        "company_change": -1.46,
        "company_percent_change": -2.4,
        "company_optionable": 1,
        "company_number_of_shares": 224526128,
        "price_change_sparkline": [
            [
                58.77,
                1706677200
            ],
            [
                59.16,
                1706763600
            ],
            [
                58.35,
                1706850000
            ],
            [
                58.06,
                1707109200
            ],
            [
                59.63,
                1707195600
            ],
            [
                57.34,
                1707282000
            ],
            [
                57.36,
                1707368400
            ],
            [
                57.66,
                1707454800
            ],
            [
                57.84,
                1707714000
            ],
            [
                59.34,
                1707800400
            ],
            [
                57.89,
                1707886800
            ],
            [
                58.97,
                1707973200
            ],
            [
                57.96,
                1708059600
            ],
            [
                58.82,
                1708405200
            ],
            [
                60.33,
                1708491600
            ],
            [
                60.91,
                1708578000
            ],
            [
                60.59,
                1708664400
            ],
            [
                60.53,
                1708923600
            ],
            [
                61,
                1709010000
            ],
            [
                59.98,
                1709096400
            ],
            [
                58.36,
                1709182800
            ],
            [
                59.05,
                1709269200
            ],
            [
                59.72,
                1709528400
            ],
            [
                58.9,
                1709614800
            ],
            [
                59.26,
                1709701200
            ],
            [
                59.03,
                1709787600
            ],
            [
                60.02,
                1709874000
            ],
            [
                60.79,
                1710129600
            ],
            [
                59.33,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2341,
        "drug_name": "IMCIVREE (setmelanotide)",
        "clinical_trial_id": "NCT03746522",
        "has_trial_insight_page": 0,
        "indication": "Bardet-Biedl Syndrome",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-16",
        "link": "https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-treatment-weight-management-patients-bardet-biedl-syndrome-aged-6-or-older",
        "note": "Approved June 16, 2022. ",
        "company_entity_id": 455,
        "company_ticker": "RYTM",
        "company_name": "Rhythm Pharmaceuticals Inc.",
        "company_price": "40.1800",
        "company_change": -0.32999999999999996,
        "company_percent_change": -0.81,
        "company_optionable": 1,
        "company_number_of_shares": 60140495,
        "price_change_sparkline": [
            [
                44.11,
                1706677200
            ],
            [
                46.33,
                1706763600
            ],
            [
                44.88,
                1706850000
            ],
            [
                45.99,
                1707109200
            ],
            [
                47.64,
                1707195600
            ],
            [
                47.79,
                1707282000
            ],
            [
                47.55,
                1707368400
            ],
            [
                51.18,
                1707454800
            ],
            [
                52.44,
                1707714000
            ],
            [
                48.9,
                1707800400
            ],
            [
                50.05,
                1707886800
            ],
            [
                50.47,
                1707973200
            ],
            [
                49.23,
                1708059600
            ],
            [
                49.11,
                1708405200
            ],
            [
                48.81,
                1708491600
            ],
            [
                44.06,
                1708578000
            ],
            [
                45.16,
                1708664400
            ],
            [
                46.15,
                1708923600
            ],
            [
                46.03,
                1709010000
            ],
            [
                44.38,
                1709096400
            ],
            [
                43.42,
                1709182800
            ],
            [
                43.71,
                1709269200
            ],
            [
                42.12,
                1709528400
            ],
            [
                41.24,
                1709614800
            ],
            [
                41.1,
                1709701200
            ],
            [
                41.67,
                1709787600
            ],
            [
                41.94,
                1709874000
            ],
            [
                40.51,
                1710129600
            ],
            [
                40.18,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6495,
        "drug_name": "Comirnaty (BNT162b2)",
        "clinical_trial_id": "NCT04368728",
        "has_trial_insight_page": 0,
        "indication": "COVID-19 vaccine",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-17",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/84201",
        "note": "EUA approval for children 4 years - 6 months, noted June 17, 2022.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6495,
        "drug_name": "Comirnaty (BNT162b2)",
        "clinical_trial_id": "NCT04368728",
        "has_trial_insight_page": 0,
        "indication": "COVID-19 vaccine",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-17",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/84201",
        "note": "EUA approval for children 4 years - 6 months, noted June 17, 2022.",
        "company_entity_id": 707,
        "company_ticker": "BNTX",
        "company_name": "BioNTech SE",
        "company_price": "95.7300",
        "company_change": -0.5700000000000001,
        "company_percent_change": -0.5900000000000001,
        "company_optionable": 1,
        "company_number_of_shares": 240993998,
        "price_change_sparkline": [
            [
                95.04,
                1706677200
            ],
            [
                94.51,
                1706763600
            ],
            [
                92.65,
                1706850000
            ],
            [
                93.35,
                1707109200
            ],
            [
                96,
                1707195600
            ],
            [
                95.05,
                1707282000
            ],
            [
                94.1,
                1707368400
            ],
            [
                93.14,
                1707454800
            ],
            [
                93.86,
                1707714000
            ],
            [
                90.58,
                1707800400
            ],
            [
                91.46,
                1707886800
            ],
            [
                92.91,
                1707973200
            ],
            [
                91.67,
                1708059600
            ],
            [
                91.24,
                1708405200
            ],
            [
                92.74,
                1708491600
            ],
            [
                93.57,
                1708578000
            ],
            [
                93.97,
                1708664400
            ],
            [
                93.52,
                1708923600
            ],
            [
                92.79,
                1709010000
            ],
            [
                91.43,
                1709096400
            ],
            [
                88.96,
                1709182800
            ],
            [
                90.94,
                1709269200
            ],
            [
                89.3,
                1709528400
            ],
            [
                90.52,
                1709614800
            ],
            [
                91.39,
                1709701200
            ],
            [
                91.09,
                1709787600
            ],
            [
                91.27,
                1709874000
            ],
            [
                96.3,
                1710129600
            ],
            [
                95.73,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6396,
        "drug_name": "SKYRIZI (risankizumab)",
        "clinical_trial_id": "NCT03104413",
        "has_trial_insight_page": 0,
        "indication": "Crohn\u2019s Disease",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-17",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ABBV\/news\/84192",
        "note": "Approved June 17, 2022. ",
        "company_entity_id": 369,
        "company_ticker": "ABBV",
        "company_name": "AbbVie Inc.",
        "company_price": "180.9200",
        "company_change": 1.29,
        "company_percent_change": 0.72,
        "company_optionable": 1,
        "company_number_of_shares": 1766473359,
        "price_change_sparkline": [
            [
                164.4,
                1706677200
            ],
            [
                167.59,
                1706763600
            ],
            [
                168.67,
                1706850000
            ],
            [
                171.26,
                1707109200
            ],
            [
                173.29,
                1707195600
            ],
            [
                175.01,
                1707282000
            ],
            [
                174.79,
                1707368400
            ],
            [
                174.08,
                1707454800
            ],
            [
                173.07,
                1707714000
            ],
            [
                173.29,
                1707800400
            ],
            [
                174.42,
                1707886800
            ],
            [
                176.59,
                1707973200
            ],
            [
                177.49,
                1708059600
            ],
            [
                175.75,
                1708405200
            ],
            [
                175.14,
                1708491600
            ],
            [
                176.75,
                1708578000
            ],
            [
                178.09,
                1708664400
            ],
            [
                178.81,
                1708923600
            ],
            [
                178.99,
                1709010000
            ],
            [
                178,
                1709096400
            ],
            [
                176.05,
                1709182800
            ],
            [
                178.91,
                1709269200
            ],
            [
                177.05,
                1709528400
            ],
            [
                179.16,
                1709614800
            ],
            [
                181.06,
                1709701200
            ],
            [
                180.57,
                1709787600
            ],
            [
                178.85,
                1709874000
            ],
            [
                179.63,
                1710129600
            ],
            [
                180.92,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 8176,
        "drug_name": "VAXNEUVANCE (V114-029)  - (PNEU-PED)",
        "clinical_trial_id": "NCT03893448",
        "has_trial_insight_page": 0,
        "indication": "Pneumococcal Vaccine in children",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-22",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/MRK\/news\/84422",
        "note": "Approved June 22, 2022.",
        "company_entity_id": 383,
        "company_ticker": "MRK",
        "company_name": "Merck & Company Inc.",
        "company_price": "122.6600",
        "company_change": -0.10999999999999999,
        "company_percent_change": -0.08999999999999997,
        "company_optionable": 1,
        "company_number_of_shares": 2532643872,
        "price_change_sparkline": [
            [
                120.78,
                1706677200
            ],
            [
                126.38,
                1706763600
            ],
            [
                126.41,
                1706850000
            ],
            [
                126.18,
                1707109200
            ],
            [
                126.88,
                1707195600
            ],
            [
                127.47,
                1707282000
            ],
            [
                126.61,
                1707368400
            ],
            [
                125.45,
                1707454800
            ],
            [
                125.34,
                1707714000
            ],
            [
                125.43,
                1707800400
            ],
            [
                125.82,
                1707886800
            ],
            [
                126.54,
                1707973200
            ],
            [
                127.79,
                1708059600
            ],
            [
                127.37,
                1708405200
            ],
            [
                128.12,
                1708491600
            ],
            [
                129.26,
                1708578000
            ],
            [
                129.45,
                1708664400
            ],
            [
                128.84,
                1708923600
            ],
            [
                129.03,
                1709010000
            ],
            [
                128.19,
                1709096400
            ],
            [
                127.15,
                1709182800
            ],
            [
                126.96,
                1709269200
            ],
            [
                124.05,
                1709528400
            ],
            [
                122.83,
                1709614800
            ],
            [
                123.75,
                1709701200
            ],
            [
                123.99,
                1709787600
            ],
            [
                123.5,
                1709874000
            ],
            [
                122.77,
                1710129600
            ],
            [
                122.66,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9504,
        "drug_name": "Clorazepate Dipotassium Tablets",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Tranxene generic ",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-22",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ANIP\/news\/84423",
        "note": "Approved June 22, 2022. ",
        "company_entity_id": 792,
        "company_ticker": "ANIP",
        "company_name": "ANI Pharmaceuticals Inc.",
        "company_price": "66.5400",
        "company_change": 0.41,
        "company_percent_change": 0.62,
        "company_optionable": 1,
        "company_number_of_shares": 21078986,
        "price_change_sparkline": [
            [
                55.82,
                1706677200
            ],
            [
                56.51,
                1706763600
            ],
            [
                55.42,
                1706850000
            ],
            [
                56.04,
                1707109200
            ],
            [
                56.87,
                1707195600
            ],
            [
                56.03,
                1707282000
            ],
            [
                55.91,
                1707368400
            ],
            [
                56.51,
                1707454800
            ],
            [
                57.03,
                1707714000
            ],
            [
                55.02,
                1707800400
            ],
            [
                56.1,
                1707886800
            ],
            [
                57.55,
                1707973200
            ],
            [
                59.72,
                1708059600
            ],
            [
                58.37,
                1708405200
            ],
            [
                57.63,
                1708491600
            ],
            [
                58.15,
                1708578000
            ],
            [
                59.13,
                1708664400
            ],
            [
                60.25,
                1708923600
            ],
            [
                59.94,
                1709010000
            ],
            [
                60.28,
                1709096400
            ],
            [
                67.67,
                1709182800
            ],
            [
                67.17,
                1709269200
            ],
            [
                66.42,
                1709528400
            ],
            [
                65.34,
                1709614800
            ],
            [
                65.81,
                1709701200
            ],
            [
                66.71,
                1709787600
            ],
            [
                67.42,
                1709874000
            ],
            [
                66.13,
                1710129600
            ],
            [
                66.54,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9507,
        "drug_name": "Tafinlar (dabrafenib) + Mekinist (trametinib)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Solid tumors in adult and pediatric patients",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-22",
        "link": "https:\/\/www.prnewswire.com\/news-releases\/novartis-tafinlar--mekinist-receives-fda-approval-for-first-tumor-agnostic-indication-for-braf-v600e-solid-tumors-301573580.html",
        "note": "Approved June 22, 2022. ",
        "company_entity_id": 386,
        "company_ticker": "NVS",
        "company_name": "Novartis AG",
        "company_price": "99.7700",
        "company_change": -1.6,
        "company_percent_change": -1.58,
        "company_optionable": 1,
        "company_number_of_shares": 2044033986,
        "price_change_sparkline": [
            [
                99.701426650332,
                1706677200
            ],
            [
                101.493681927897,
                1706763600
            ],
            [
                99.9423211768864,
                1706850000
            ],
            [
                99.701426650332,
                1707109200
            ],
            [
                99.9615927390107,
                1707195600
            ],
            [
                99.6917908692698,
                1707282000
            ],
            [
                97.6682768462129,
                1707368400
            ],
            [
                97.3502960711611,
                1707454800
            ],
            [
                96.8685070180523,
                1707714000
            ],
            [
                95.4520472019125,
                1707800400
            ],
            [
                95.4424114208503,
                1707886800
            ],
            [
                96.0012867224565,
                1707973200
            ],
            [
                96.5408904619384,
                1708059600
            ],
            [
                98.9787430706688,
                1708405200
            ],
            [
                98.824570573674,
                1708491600
            ],
            [
                99.0558293191662,
                1708578000
            ],
            [
                100.115765236006,
                1708664400
            ],
            [
                99.4894394669641,
                1708923600
            ],
            [
                99.3930816563424,
                1709010000
            ],
            [
                98.49695401756,
                1709096400
            ],
            [
                97.2924813847881,
                1709182800
            ],
            [
                98.3427815205652,
                1709269200
            ],
            [
                98.2560594910056,
                1709528400
            ],
            [
                98.3813246448139,
                1709614800
            ],
            [
                98.9016568221714,
                1709701200
            ],
            [
                99.93,
                1709787600
            ],
            [
                100.71,
                1709874000
            ],
            [
                101.37,
                1710129600
            ],
            [
                99.77,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 8991,
        "drug_name": "Breyanzi (lisocabtagene maraleucel)",
        "clinical_trial_id": "NCT03575351",
        "has_trial_insight_page": 0,
        "indication": "Large B-cell lymphoma (LBCL)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-06-24",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BMY\/news\/84706",
        "note": "Approved June 24, 2022.",
        "company_entity_id": 376,
        "company_ticker": "BMY",
        "company_name": "Bristol-Myers Squibb Company",
        "company_price": "54.4000",
        "company_change": 0.04,
        "company_percent_change": 0.07,
        "company_optionable": 1,
        "company_number_of_shares": 2022193411,
        "price_change_sparkline": [
            [
                48.87,
                1706677200
            ],
            [
                48.67,
                1706763600
            ],
            [
                48.71,
                1706850000
            ],
            [
                47.98,
                1707109200
            ],
            [
                49.26,
                1707195600
            ],
            [
                48.64,
                1707282000
            ],
            [
                48.71,
                1707368400
            ],
            [
                49.81,
                1707454800
            ],
            [
                49.75,
                1707714000
            ],
            [
                48.71,
                1707800400
            ],
            [
                48.89,
                1707886800
            ],
            [
                49.44,
                1707973200
            ],
            [
                49.86,
                1708059600
            ],
            [
                49.86,
                1708405200
            ],
            [
                50.91,
                1708491600
            ],
            [
                51.33,
                1708578000
            ],
            [
                51.66,
                1708664400
            ],
            [
                50.52,
                1708923600
            ],
            [
                50.51,
                1709010000
            ],
            [
                50.92,
                1709096400
            ],
            [
                50.75,
                1709182800
            ],
            [
                50.89,
                1709269200
            ],
            [
                50.92,
                1709528400
            ],
            [
                51.82,
                1709614800
            ],
            [
                53.38,
                1709701200
            ],
            [
                53.28,
                1709787600
            ],
            [
                53.79,
                1709874000
            ],
            [
                54.36,
                1710129600
            ],
            [
                54.4,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5878,
        "drug_name": "Krystexxa (pegloticase injection) with Methotrexate",
        "clinical_trial_id": "NCT03994731",
        "has_trial_insight_page": 0,
        "indication": "Uncontrolled Gout",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-07-08",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/HZNP\/news\/85655",
        "note": "Approved July 8, 2022.",
        "company_entity_id": 372,
        "company_ticker": "AMGN",
        "company_name": "Amgen Inc.",
        "company_price": "276.5400",
        "company_change": 1.18,
        "company_percent_change": 0.43,
        "company_optionable": 1,
        "company_number_of_shares": 535918901,
        "price_change_sparkline": [
            [
                311.832823699025,
                1706677200
            ],
            [
                322.053272003295,
                1706763600
            ],
            [
                320.693853151174,
                1706850000
            ],
            [
                319.483275779212,
                1707109200
            ],
            [
                313.62884422628,
                1707195600
            ],
            [
                293.584858231498,
                1707282000
            ],
            [
                292.572736166415,
                1707368400
            ],
            [
                288.871544693121,
                1707454800
            ],
            [
                292.155980021969,
                1707714000
            ],
            [
                288.236487711108,
                1707800400
            ],
            [
                287.829654332006,
                1707886800
            ],
            [
                289.07,
                1707973200
            ],
            [
                283.7,
                1708059600
            ],
            [
                283.51,
                1708405200
            ],
            [
                283.46,
                1708491600
            ],
            [
                285.18,
                1708578000
            ],
            [
                289.18,
                1708664400
            ],
            [
                286.37,
                1708923600
            ],
            [
                278.49,
                1709010000
            ],
            [
                277.46,
                1709096400
            ],
            [
                273.83,
                1709182800
            ],
            [
                280.33,
                1709269200
            ],
            [
                279.39,
                1709528400
            ],
            [
                276.65,
                1709614800
            ],
            [
                276.59,
                1709701200
            ],
            [
                272.86,
                1709787600
            ],
            [
                273.75,
                1709874000
            ],
            [
                275.36,
                1710129600
            ],
            [
                276.54,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6449,
        "drug_name": "NVX-CoV2373",
        "clinical_trial_id": "NCT04611802",
        "has_trial_insight_page": 0,
        "indication": "COVID-19 vaccine",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-07-13",
        "link": "https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-emergency-use-novavax-covid-19-vaccine-adjuvanted",
        "note": "Emergency Use Authorization (EUA) granted July 13, 2022.",
        "company_entity_id": 215,
        "company_ticker": "NVAX",
        "company_name": "Novavax Inc.",
        "company_price": "5.0600",
        "company_change": -0.06999999999999995,
        "company_percent_change": -1.3599999999999999,
        "company_optionable": 1,
        "company_number_of_shares": 139953143,
        "price_change_sparkline": [
            [
                4,
                1706677200
            ],
            [
                4.02,
                1706763600
            ],
            [
                3.93,
                1706850000
            ],
            [
                3.76,
                1707109200
            ],
            [
                3.93,
                1707195600
            ],
            [
                3.78,
                1707282000
            ],
            [
                3.79,
                1707368400
            ],
            [
                4.03,
                1707454800
            ],
            [
                4.15,
                1707714000
            ],
            [
                3.9,
                1707800400
            ],
            [
                4.1,
                1707886800
            ],
            [
                4.3,
                1707973200
            ],
            [
                4.16,
                1708059600
            ],
            [
                4.13,
                1708405200
            ],
            [
                3.98,
                1708491600
            ],
            [
                4.88,
                1708578000
            ],
            [
                5.29,
                1708664400
            ],
            [
                5.5,
                1708923600
            ],
            [
                6.02,
                1709010000
            ],
            [
                4.41,
                1709096400
            ],
            [
                4.94,
                1709182800
            ],
            [
                5.39,
                1709269200
            ],
            [
                5.49,
                1709528400
            ],
            [
                5.57,
                1709614800
            ],
            [
                5.61,
                1709701200
            ],
            [
                5.61,
                1709787600
            ],
            [
                5.45,
                1709874000
            ],
            [
                5.13,
                1710129600
            ],
            [
                5.06,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5759,
        "drug_name": "ZONISADE (Zonisamide Oral Suspension)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Epilepsy",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-07-18",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ETON\/news\/86310",
        "note": "Approved July 18, 2022.",
        "company_entity_id": 611,
        "company_ticker": "ETON",
        "company_name": "Eton Pharmaceuticals Inc.",
        "company_price": "4.4000",
        "company_change": -0.16000000000000003,
        "company_percent_change": -3.51,
        "company_optionable": 1,
        "company_number_of_shares": 25658396,
        "price_change_sparkline": [
            [
                4.67,
                1706677200
            ],
            [
                4.6,
                1706763600
            ],
            [
                4.49,
                1706850000
            ],
            [
                4.58,
                1707109200
            ],
            [
                4.72,
                1707195600
            ],
            [
                4.58,
                1707282000
            ],
            [
                4.41,
                1707368400
            ],
            [
                4.41,
                1707454800
            ],
            [
                4.41,
                1707714000
            ],
            [
                4.42,
                1707800400
            ],
            [
                4.39,
                1707886800
            ],
            [
                4.59,
                1707973200
            ],
            [
                4.4,
                1708059600
            ],
            [
                4.36,
                1708405200
            ],
            [
                4.45,
                1708491600
            ],
            [
                4.47,
                1708578000
            ],
            [
                4.47,
                1708664400
            ],
            [
                4.47,
                1708923600
            ],
            [
                4.49,
                1709010000
            ],
            [
                4.48,
                1709096400
            ],
            [
                4.45,
                1709182800
            ],
            [
                4.46,
                1709269200
            ],
            [
                4.47,
                1709528400
            ],
            [
                4.38,
                1709614800
            ],
            [
                4.33,
                1709701200
            ],
            [
                4.49,
                1709787600
            ],
            [
                4.5,
                1709874000
            ],
            [
                4.56,
                1710129600
            ],
            [
                4.4,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4958,
        "drug_name": "Ruxolitinib Cream (Opzelura)",
        "clinical_trial_id": "NCT04052425",
        "has_trial_insight_page": 0,
        "indication": "Vitiligo",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2022-07-19",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/INCY\/news\/86398",
        "note": "Approved July 19, 2022.",
        "company_entity_id": 167,
        "company_ticker": "INCY",
        "company_name": "Incyte Corporation",
        "company_price": "59.3300",
        "company_change": -1.46,
        "company_percent_change": -2.4,
        "company_optionable": 1,
        "company_number_of_shares": 224526128,
        "price_change_sparkline": [
            [
                58.77,
                1706677200
            ],
            [
                59.16,
                1706763600
            ],
            [
                58.35,
                1706850000
            ],
            [
                58.06,
                1707109200
            ],
            [
                59.63,
                1707195600
            ],
            [
                57.34,
                1707282000
            ],
            [
                57.36,
                1707368400
            ],
            [
                57.66,
                1707454800
            ],
            [
                57.84,
                1707714000
            ],
            [
                59.34,
                1707800400
            ],
            [
                57.89,
                1707886800
            ],
            [
                58.97,
                1707973200
            ],
            [
                57.96,
                1708059600
            ],
            [
                58.82,
                1708405200
            ],
            [
                60.33,
                1708491600
            ],
            [
                60.91,
                1708578000
            ],
            [
                60.59,
                1708664400
            ],
            [
                60.53,
                1708923600
            ],
            [
                61,
                1709010000
            ],
            [
                59.98,
                1709096400
            ],
            [
                58.36,
                1709182800
            ],
            [
                59.05,
                1709269200
            ],
            [
                59.72,
                1709528400
            ],
            [
                58.9,
                1709614800
            ],
            [
                59.26,
                1709701200
            ],
            [
                59.03,
                1709787600
            ],
            [
                60.02,
                1709874000
            ],
            [
                60.79,
                1710129600
            ],
            [
                59.33,
                1710216000
            ]
        ],
        "statuses": []
    }
]